ProRx Pharma has announced the addition of six injectable products to its portfolio, aimed at supporting the growing demand ...

Long a lobbying powerhouse in Washington, pharma’s struggling to settle on a strategy for defending itself, according to six industry lobbyists and three company officials who spoke to POLITICO. All ...

The Trump administration’s threat of pharmaceutical tariffs could risk significant political backlash, as the drug industry ...

PCI Pharma Services, (“PCI”)a leading global contract development and manufacturing ...

Irish exports of pharmaceutical and medical products to the U.S. surged by more than 450% year-on-year in February, data ...

Acquisition creates a world-class large-scale manufacturing hub in San Diego region with state-of-the-art aseptic facilities ...

Zealand Pharma appoints Utpal Singh as Chief Scientific Officer to drive next-generation peptide therapeutics discovery Utpal ...

Vishal Manchanda, Pharma Analyst at Systematix Group, advised avoiding companies with high dependence on the US market—such ...

Leveraging Trump’s impending tariffs, pharma companies have called on Europe again to change regulation, threatening a US ...

The level on tariffs on Chinese origin products is astronomical. We also have a 10% tariff on products from Europe, with a carve out for very specific pharmaceutical products. How long that will last ...